These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24709521)

  • 41. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
    Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
    J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
    Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
    Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermoresponsive Supramolecular Chemotherapy by "V"-Shaped Armed β-Cyclodextrin Star Polymer to Overcome Drug Resistance.
    Fan X; Cheng H; Wang X; Ye E; Loh XJ; Wu YL; Li Z
    Adv Healthc Mater; 2018 Apr; 7(7):e1701143. PubMed ID: 29280358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Polymer and oligomer based doxorubicin carriers].
    Kik K; Lwow F; Szmigiero L
    Polim Med; 2007; 37(1):47-55. PubMed ID: 17703723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
    Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
    Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
    Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
    Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
    Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
    Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
    Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
    Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
    Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
    J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
    J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
    Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
    Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
    Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
    Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.
    Lammers T; Subr V; Ulbrich K; Peschke P; Huber PE; Hennink WE; Storm G
    Biomaterials; 2009 Jul; 30(20):3466-75. PubMed ID: 19304320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
    Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
    Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
    Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
    J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.